# Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

> **NCT06712563** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 2000 (estimated)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Budesonide/glycopyrrolate/formoterol fumarate

## Key facts

- **NCT ID:** NCT06712563
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-17
- **Primary completion:** 2026-12-14
- **Final completion:** 2026-12-14
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06712563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06712563, "Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT06712563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*